Literature DB >> 32187572

Long-term environmental exposure to microcystins increases the risk of nonalcoholic fatty liver disease in humans: A combined fisher-based investigation and murine model study.

Yanyan Zhao1, Yunjun Yan2, Liqiang Xie3, Lixiao Wang2, Yaojia He2, Xiang Wan3, Qingju Xue3.   

Abstract

Microcystins (MCs) produced by cyanobacteria pose serious threats to human health. However, the contribution of long-term exposure to MCs to the development of nonalcoholic fatty liver disease (NAFLD) remains poorly documented. In this study, we estimated the environmental uptake of MCs by a small population of fishers who have lived for many years on Meiliang Bay of Lake Taihu, where cyanobacterial blooms occur frequently. Serum biochemical indices of liver function and their relationships with MC contamination in these people were also investigated. Moreover, to mimic the long-term effects of MC on the livers of fishers, an animal model was established in which mice were exposed to MC-LR at an environmentally relevant level, a reference level (the no-observed adverse effect level, NOAEL), and three times the NOAEL through drinking water for 12 months. We estimated the total daily intake of MCs by fishers through contaminated lake water and food to be 5.95 μg MC-LReq, far exceeding the tolerable daily intake (2.40 μg MC-LReq) proposed by the World Health Organization (WHO). More than 80% of participants had at least one abnormal serum marker. The indices of aspartate aminotransferase (AST)/alanine aminotransferase (ALT), triglyceride (TG), globulin (GLB), and lactate dehydrogenase (LDH) had close positive associations with MC contamination, indicating that both liver damage and lipid metabolism dysfunction were induced by chronic MC exposure. Furthermore, the animal experimental results showed that long-term exposure to MC-LR at the environmentally relevant level led to hepatic steatosis with molecular alterations in circadian rhythm regulation, lipid metabolic processes, and the cell cycle pathway. Exposure to MC-LR at or above the NOAEL worsened the pathological phenotype towards nonalcoholic steatohepatitis disease (NASH) or fibrosis. These results suggest that prolonged exposure to the reference level (NOAEL) of MC-LR could cause severe liver injury to mammals. People with long-term environmental exposure to MCs might be at high risk for developing NAFLD.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Fishers; Long-term exposure; Microcystins; Molecular mechanisms; Nonalcoholic fatty liver disease

Year:  2020        PMID: 32187572     DOI: 10.1016/j.envint.2020.105648

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  5 in total

1.  Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent.

Authors:  Ayan Mondal; Punnag Saha; Dipro Bose; Somdatta Chatterjee; Ratanesh K Seth; Shuo Xiao; Dwayne E Porter; Bryan W Brooks; Geoff I Scott; Mitzi Nagarkatti; Prakash Nagarkatti; Saurabh Chatterjee
Journal:  Toxicology       Date:  2021-08-17       Impact factor: 4.571

Review 2.  A Mini Review on Microcystins and Bacterial Degradation.

Authors:  Isaac Yaw Massey; Fei Yang
Journal:  Toxins (Basel)       Date:  2020-04-21       Impact factor: 4.546

Review 3.  Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans.

Authors:  Tarana Arman; John D Clarke
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

Review 4.  Immobilization of Microbes for Biodegradation of Microcystins: A Mini Review.

Authors:  Jiajia Zhang; Jia Wei; Isaac Yaw Massey; Tangjian Peng; Fei Yang
Journal:  Toxins (Basel)       Date:  2022-08-22       Impact factor: 5.075

Review 5.  Environmental Risk Factors Implicated in Liver Disease: A Mini-Review.

Authors:  Rajesh Melaram
Journal:  Front Public Health       Date:  2021-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.